Activated HER-receptors in predicting outcome of ER-positive breast cancer patients treated with adjuvant endocrine therapy
about
Inverse regulation of EGFR/HER1 and HER2-4 in normal and malignant human breast tissue.Biology and therapeutic potential of PI3K signaling in ER+/HER2-negative breast cancer.A high level of estrogen-stimulated proteins selects breast cancer patients treated with adjuvant endocrine therapy with good prognosis.Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4-1 and NRDP1, in primary breast cancer
P2860
Activated HER-receptors in predicting outcome of ER-positive breast cancer patients treated with adjuvant endocrine therapy
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Activated HER-receptors in pre ...... ith adjuvant endocrine therapy
@ast
Activated HER-receptors in pre ...... ith adjuvant endocrine therapy
@en
type
label
Activated HER-receptors in pre ...... ith adjuvant endocrine therapy
@ast
Activated HER-receptors in pre ...... ith adjuvant endocrine therapy
@en
prefLabel
Activated HER-receptors in pre ...... ith adjuvant endocrine therapy
@ast
Activated HER-receptors in pre ...... ith adjuvant endocrine therapy
@en
P2093
P2860
P1433
P1476
Activated HER-receptors in pre ...... ith adjuvant endocrine therapy
@en
P2093
Anita Giobbie-Hurder
Anne E Lykkesfeldt
Birgitte B Rasmussen
Karsten Bjerre
Katrine L Henriksen
Mathilde S Larsen
P2860
P304
P356
10.1016/J.BREAST.2012.07.005
P577
2012-07-31T00:00:00Z